http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5515415-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_620ecb9324409347c27e96b6071503ee
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D521-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-10
filingDate 1978-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bb9b193ff512254268a38ea11f19003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d89846df8128952f5e942b76ec537b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08572600762c2dc44fc238a6d51a0d71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f6ce15408c0656c5100cfcfe3a5d0a7
publicationDate 1980-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S5515415-A
titleOfInvention Heterocyclic compound and its preparation
abstract NEW MATERIAL:A heterocyclic compound of formula I: (Het is nitrogen-containing five-or six-membered heterocyclic group; Z is S or O; R 1 is H, alkyl, cyano, carbamoyl group, etc.; Y is alkenyl, alkynyl, substituted amino group, etc.; m and n are integers 1W3), or its acid addition salt. n EXAMPLE: 3-(2-Pyridylmethylthio)-N-trichloroacetyl propionamidine hydrate. n USE: Suppressants for secretion of acid in the stomach, having the action without the anticholinergic action. The compound comprises a substance to suppress the secretion based on the histamine H 2 acceptor antagonism. n PROCESS: A compound of formula III is reacted with an amine of the formula H 2 NY to give the objective compound of formula I. n COPYRIGHT: (C)1980,JPO&Japio
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0438697-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S59107926-A
priorityDate 1978-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457574898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70588573
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579030
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236635235

Total number of triples: 35.